PSC
GERN icon

Patient Square Capital’s Geron GERN Stock Holding History

Patient Square Capital’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-845,000
Closed -$1.16M – 31
2025
Q3 		$1.16M Buy
845,000
+129,000
+18% +$172K 0.31% 24
2025
Q2 		$1.01M Buy
+716,000
New +$1.02M 0.36% 17
2025
Q1 		– Sell
-1,321,268
Closed -$4.68M – 22
2024
Q4 		$4.68M Buy
+1,321,268
New +$5.28M 1.75% 9

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Patient Square Capital's GERN Position: Q4 2025 in Review

Patient Square Capital sold out of Geron (GERN) in Q4 2025, closing a stake of 845,000 shares — an estimated $1.16M sold.

Patient Square Capital first reported a position in GERN in Q4 2024 and held it in 3 quarters. The position peaked at $4.68M in Q4 2024. 262 funds tracked by Wall St. Rank hold GERN as of Q4 2025.

  • Patient Square Capital reported no remaining Geron position as of Q4 2025 after selling out during the quarter.
  • Patient Square Capital sold 845,000 Geron shares in Q4 2025, an estimated $1.16M.
  • Patient Square Capital first reported a position in Geron in Q4 2024 and held it in 3 quarters.
  • Patient Square Capital's Geron position peaked at $4.68M in Q4 2024.
  • 262 funds tracked by Wall St. Rank held Geron as of Q4 2025.

Based on Patient Square Capital's 13F filing for Q4 2025, filed 12 Feb 2026.